An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update
Authors:
- 9 September 2022
- journal article
- review article
- Published by Elsevier in Psychiatry Research
- Vol. 317, 114840
Abstract
No abstract availableKeywords
This publication has 167 references indexed in Scilit:
- The Impact of Posttraumatic Stress Disorder on CPAP Adherence in Patients with Obstructive Sleep ApneaJournal of Clinical Sleep Medicine, 2012
- Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military VeteransJournal of Psychosomatic Research, 2012
- Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational InsomniaNeuropsychopharmacology, 2012
- Noradrenergic vs Serotonergic Antidepressant with or without Naltrexone for Veterans with PTSD and Comorbid Alcohol DependenceNeuropsychopharmacology, 2011
- Race/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United StatesPsychological Medicine, 2010
- Post-traumatic stress disorder: emerging concepts of pharmacotherapyExpert Opinion on Emerging Drugs, 2009
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- A Pooled Analysis of Gender and Trauma-Type Effects on Responsiveness to Treatment of PTSD With Venlafaxine Extended Release or PlaceboThe Journal of Clinical Psychiatry, 2008
- Prazosin Effects on Objective Sleep Measures and Clinical Symptoms in Civilian Trauma Posttraumatic Stress Disorder: A Placebo-Controlled StudyBiological Psychiatry, 2008
- A Randomized, Double-Blind, Placebo-Controlled Trial of Augmentation Topiramate for Chronic Combat-Related Posttraumatic Stress DisorderJournal of Clinical Psychopharmacology, 2007